No summary for this episode yet.
In today's market, one of the most precious commodities you can add to your portfolio is certainty, the kind you get with a multi-year guarantee annuity from American National Insurance Company. Your money grows at a steady rate, guaranteed, no hidden fees, no market risk, no surprises, just a bedrock of certainty you can depend on to be there when you need it most. You can get more details and fund an annuity online at annuities.americanational.com. You got this. Disney pulls Jimmy Kimmel off the air after his remarks on slain conservative activist Charlie Kirk. Plus, Novo Nordisk's experimental weight loss pill shows strong results in a late-stage trial.
Weekly injectables, they've just generated huge sales. But the companies that have developed those haven't rested on their laurels. And they feel that there is a demand for pill versions of these drugs. And Britain's prime minister, otherwise known as Europe's Trump whisperer, prepares for a meeting with the president. It's Thursday, September 18th. I'm Caitlin McCabe for The Wall Street Journal. And here's the AM edition of What's News, the top headlines and business stories moving your world today. Disney has pulled popular late night host Jimmy Kimmel off ABC indefinitely. following remarks he made about the fatal shooting of conservative activist Charlie Kirk.
We hit some new lows over the weekend with the MAGA gang desperately trying to characterize this kid who murdered Charlie Kirk as anything other than one of them and doing everything they can to score political points from it. The decision came just hours after the chair of the Federal Communications Commission, Brendan Carr, criticized Kimmel on a conservative political podcast, where he suggested the agency could take action against the broadcast licenses of ABC-owned stations. People familiar with the matter said senior leadership, including Disney CEO Bob Iger, were among those who decided to pull Kimmel immediately.
We should note that a spokesman for Kimmel said the host had no comment. Kirk's killing has become a deeply divisive issue over the last week. People who have condemned Kirk's rhetoric, gloated over his death, or criticized the White House's response to it, have found themselves facing sharp rebuke. In Washington, Republicans attempted to censure Democratic Representative Ilhan Omar for reposting a video that disparaged Kirk. Democrats defeated the effort last night. We're exclusively reporting that some military lawyers and other Defense Department officials are raising concerns about the legal implications of President Trump's growing military campaign against Latin American-based drug cartels.
Twice this month, the U.S. has attacked boats it believed were transporting illegal drugs in international waters. Officials have raised concerns about the justification for the strikes and the legal implications for military personnel who have been involved. But people familiar with the matter said those opinions were deliberately ignored or sidelined by Pentagon leaders. A spokesman for the Pentagon denied that any department lawyers have raised concerns and said that the administration's current operations are lawful under U.S. and international law. And Canadian Prime Minister Mark Carney is in Mexico today to meet with President Claudia Sheinbaum.
America's neighbors are preparing for next year's review of their free trade deal with the U.S. More than 75 percent of Canada's exports and more than 80 percent of Mexico's go to America. Our deputy Latin America editor Santiago Perez says Canada and Mexico are looking to improve bilateral ties because preserving the USMCA is crucial for both economies. So the visit is quite important because there are topics in which both countries need close coordination. The auto sector is one important example, and so is the auto parts industry, in which both Mexico and Canada are highly integrated, and most of the exports go to the U.
S. This North American integration also means that a lot of car parts go from one country to the other. So reaching a trade deal that is beneficial for the three countries is a top priority, especially for Mexico and Canada. We're talking about millions of jobs at stake. And now to a major development in weight loss drugs. Novo Nordisk, the Danish pharma giant, said this morning that its daily Wagovi pill has helped patients in a late-stage trial lose about as much weight as they do when taking the company's weekly injection. Patients taking the experimental drug lost an average 16.6 percent of their weight, with a third losing up to 20 percent or more in a 64-week period.
Peter Loftus covers the weight loss industry for The Wall Street Journal and says while weekly injectables have generated huge sales, there's real demand for weight loss pills too. There's a demand from people who don't like needles, who might like the cadence of taking something once a day rather than a weekly injectable. And from a manufacturing standpoint for the companies, there's some advantages to making these in pill forms rather than weekly injectables. This is in part because the pill could cost less than current weight loss drugs. The injectables right now, they have list prices of over $1,000 a month.
In practice, their net prices are a lot lower than that, in the U.S. at least, because of discounts that the companies provide, but still are several hundred dollars a month. The analysts who follow these companies think there's at least the potential for lower prices because it's easier and less costly to make these pill versions than it is to make the injectables, which, in addition to the medication itself, come with these auto-injector devices. And so that adds some cost and complexity to manufacturing. And while this industry has been incredibly competitive, Peter said other companies are likely to enter the pill race, even as Novo Nordisk and Eli Lilly get first mover advantage.
Novo does have an opportunity to kind of shore up its market share. The problem is that it might have a limited window in enjoying that advantage because Eli Lilly has developed its own pill that could come to market. You know, a lot of these other companies, they recognize that Novo Nordisk and Eli Lilly have essentially established a duopoly with the injectables. And so they've kind of moved ahead of that to kind of aim for the next wave that even if it's a couple of years from now, they could come to market with a superior product, maybe one that helps people lose more weight than what these first pills can deliver.
It's worth noting that Novo and Eli Lilly's weight loss pills haven't been approved for use yet, with U.S. regulators expected to reach a decision by the end of the year. Coming up, investors are already looking ahead to the next potential rate cut from the Fed. And we look at the art of managing the president from Europe's so-called Trump whisperer. Those stories after the break. At KPMG, we make the difference by creating value, like developing strategic insights that help drive M&A success or embedding AI solutions into your business to sustain competitive advantage. KPMG, make the difference.
Learn more at www.kpmg.us. We're less than 24 hours out from the Fed's interest rate cut, and investors are already turning their attention to the next expected move. Yesterday's quarter point cut was expected, but the lack of clarity regarding how many more rate cuts are in store over the next year means we're likely to see a lot more volatility. Paul Hannon is the economics editor for Dow Jones Newswires in London. Paul, the Fed is obviously agenda setting for markets and to some extent for other central banks, too. Are there any upcoming decisions we should be looking at here? The Bank of England is today.
It is likely to leave its key rate unchanged. It's been moving very slowly and carefully while the Fed has been on pause. It's very like the Fed, actually. I mean, it faces this challenge of balancing a pickup in inflation against signs of a cooler jobs market. And while the Fed is sort of leaning towards focusing on the jobs market, the Bank of England is leaning a bit more towards worrying about inflation. So while investors sort of expect the Fed to deliver two more cuts this year, investors are thinking maybe the Bank of England will wait until early next year to make its next move. And I believe we're waiting on a decision from the Bank of Japan, too.
What are we expecting on that front, given the uncertainty over Japan's trade outlook, but also the resignation of Prime Minister Shigeru Ishiba earlier this month? They will be very, very careful. And right now, they will probably decide to leave things as they are. But I think later in the year, you'll probably see another small rate rise. You mentioned the deterioration in the U.S. economy. How does that compare to the rest of the world globally? Well, it has a big impact on the economic situation in the rest of the world. It's been a little bit clearer in the U.S. that tariffs are having an impact on both prices and the jobs market.
Europe so far appears to have been a little bit less affected by that. And that's partly to do with the level at which tariffs seem to be settling. Overnight, for example, the Irish Central Bank published some new forecasts. It raised its growth forecasts for this year and next year, basically because the 15% level at which tariffs appear to be fixed now for a little while at least is going to be less damaging than they had anticipated. But that's not to say that this is done and dusted. There's still quite a lot of uncertainty about exactly how trade is going to be conducted over the next few years.
So it's a difficult moment, I think, for central banks to be making decisions about anything. That's Paul Hannon for Dow Jones Newswires in London. Paul, thanks for being here. You're welcome. Thanks. And finally, President Trump continues his unprecedented second state visit to the UK today, where he'll meet Keir Starmer, the British prime minister who has seemingly perfected the art of handling the mercurial president. Before leaving Washington, Trump suggested he was open to making some concessions to Britain on trade. And perhaps to sweeten the deal, Britain has rolled out the red carpet for the president and Melania Trump, including a lavish dinner with King Charles III at Windsor Castle last night.
Here's Journal-White House reporter Tarini Pardi. The table itself measured 51 yards, had 139 candles and 1,452 pieces of cutlery for the 160 guests. The table took a week to put together, and the guest list, which included tech CEOs like Apple's Tim Cook and OpenAI's Sam Altman, was created by the British government, the White House, and the royal family. Officials said it was representative of the transatlantic relationship. Starmer in Britain's approach to dealing with Trump has been paying dividends for Britain, which secured an early trade deal with the U.S., a lower tariff rate compared to the European Union, and special treatment on steel and aluminum tariffs.
Downing Street, the British prime minister's office, has said the UK has also secured more than $200 billion in investments from U.S. companies to coincide with Trump's visit, including over $40 billion in new AI infrastructure investments from U.S. tech companies. Trump will meet Starmer at the prime minister's countryside retreat today, known as Checkers, where the president and first lady are expected to be presented with a range of Made in Britain gifts. And that's it for What's News for this Thursday morning. Today's show is produced by Kate Bullivant and Daniel Bach. Our supervising producer is Sandra Kilhoff.
And I'm Caitlin McCabe for The Wall Street Journal. We'll be back tonight with a new show. Until then, thanks for listening. At the heart of BlackRock Coffee Bar is more than coffee. It's the people who bring it to life. Our baristas are the soul of every interaction. storytellers connectors and quiet everyday heroes founded by family and rooted in hospitality we built a place where coffee fuels connection today we're pouring coffee serving signature fuel energy drinks and crafting memorable moments across seven states and growing join us as we fuel even more stories blackrock coffee bar proudly nasdaq listed